Biotech News

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

UnitedHealth Group (UNH)UnitedHealth Group2026-06-25 13:46 ESTClinical readout

UNH (UNH) appears in the live feed after a catalyst-style update. The headline is surfaced in real time so readers can move from signal to source without leaving the product flow.

The source domain is unh.com. BioPharmSignal keeps the ticker, timestamp, and source together for faster review before the wider market catches up.

The original release is available below in a new tab so readers can continue into the full source when needed.

Open original release

Related news

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals to Report Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity on Thursday, December 11, 2025

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals Reports Results from Phase 1a Study of Oral CB1 Inverse Agonist CRB-913 for the Treatment for Obesity Demonstrating Favorable Safety Profile and Emerging Evidence of Weight Loss

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals Reports Q4 and 2025 Financial Results and Provides a Corporate Update

UNHUnitedHealth Group2026-06-25 13:46 EST

Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit

View all latest news

UnitedHealth Group

UnitedHealth Group is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

UNHUnitedHealth Group2026-06-26 12:02 EST

Corbus Pharmaceuticals Reports Updated CRB-701 Phase 1/2 Clinical Data Demonstrating Robust Activity in 2L Oropharyngeal and Cervical Cancers

UNHUnitedHealth Group2026-06-26 12:02 EST

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

UNHUnitedHealth Group2026-06-26 12:02 EST

Corbus Pharmaceuticals Appoints Pharma Industry Veteran Brent Pfeiffenberger to Board of Directors

UNHUnitedHealth Group2026-06-26 12:02 EST

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

UNHUnitedHealth Group2026-06-26 12:02 EST

Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update

Stock data

Close: —
Market cap: —
Exchange: NYSE
Sector: Biotechnology
Location: United States